TDP-43 degrader-1 (example 3) reduces the TDP-43 aggregation that can be in the research of Amyotrophic lateral sclerosis and Alzheimer's disease.
References:
[1]. Solas Dennis, et al. Preparation of substituted isoquinolines for the treatment of ALS. United States, US20230037538 A1 2023-02-09
















